πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8404818

Monoclonal antibodies against orthopoxviruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8404244

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing anti

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8399689

Chrysophaentin antimicrobial compounds that inhibit FtsZ protein

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8394764

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nu

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8394762

Self-decontaminating coatings containing antimicrobial peptides

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8394411

Papillomavirus pseudoviruses for detection and therapy of tumors

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8394387

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8389495

Olioodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8388933

Multimeric protein toxins to target cells having multiple identifying characteristics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8383817

Benztropine compounds and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8383589

Aegyptin and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8383133

Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8383102

Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradicat

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8383099

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8378071

Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8377637

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8377450

Clone of Newcastle disease virus, its manufacture and its application in the medical treat

United Cancer Research Institute Β· Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367074

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of rec

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367058

Method for bacteriophage delivery and amplification

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8361772

Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8361710

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8361707

Methods for detecting a Mycobacterium tuberculosis infection

The United States of Americaβ€”Department of Veterans Affairs Β· Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8357783

Human anti-mesothelin monoclonal antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8357525

Thermal inactivation of rotavirus

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted